Fig. 5.
Inhibition of the binding of 150 ng/mL vWF to calfskin collagen type I (A) and of 50 ng/mL vWF to human collagen type I (B) by increasing concentrations of Q- (▴) and N-peptide (•) (mean ± SEM, n = 3).
Inhibition of the binding of 150 ng/mL vWF to calfskin collagen type I (A) and of 50 ng/mL vWF to human collagen type I (B) by increasing concentrations of Q- (▴) and N-peptide (•) (mean ± SEM, n = 3).
